AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)

NCT01360255 · clinicaltrials.gov ↗
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University Hospital Freiburg

Collaborators